MBH with Triquera on Admaius’ investment in Minapharm
Matouk Bassiouny & Hennawy (MBH) advised Triquera, the majority shareholder of Minapharm Pharmaceuticals, in connection with the subscription of a minority stake by Admaius Capital Partners (Admaius), a private equity investor with a specific focus on the African continent.
The context
Admaius completed the operation through its own investment vehicle, Virunga Healix Limited. Triquera and Admaius are thus set to partner with the scope of advancing the development and manufacture of complex genetically engineered therapies as well as scaling distribution networks across Africa and the Middle East.
The MBH team
Founding partner and group head of corporate and M&A Omar S. Bassiouny (pictured) led the MBH team on the matter, working with senior associate Salma El Refaie and associate Mayar Sharafeldin
